10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
Biomea Fusion Inc. (BMEA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cormorant Asset Management Bihua Chen | 3,570,872 | $7,213,161 | 0.5% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,300,834 | $2,627,685 | -26% | 0.01% |
| 3. | Renaissance Technologies Jim Simons | 595,900 | $1,203,718 | 0% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 294,733 | $595,362 | +762% | 0% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 266,700 | $538,734 | -11% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.99 | 100,000 | $99,180.00 | 115,000 | 2025-12-02 | Filing | |
| $1.05 | 10,000 | $10,500.00 | 693,027 | 2025-12-01 | Filing | |
| $1.10 | 40,000 | $44,052.00 | 683,027 | 2025-11-28 | Filing | |
| $10.06 | 10,000 | $100,600.00 | 15,000 | 2024-09-30 | Filing | |
| $4.43 | 12,509 | $55,361.08 | 42,500 | 2024-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.56 | 50,000 | $1,728,165.00 | 3,500,000 | 2023-06-01 | Filing | |
| $33.81 | 75,000 | $2,535,750.00 | 3,550,000 | 2023-05-31 | Filing | |
| $33.84 | 25,000 | $846,000.00 | 3,625,000 | 2023-05-12 | Filing | |
| $34.50 | 150,000 | $5,175,720.00 | 3,650,000 | 2023-05-09 | Filing | |
| $33.99 | 100,000 | $3,399,310.00 | 3,800,000 | 2023-05-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,616,852 | $15,386,041 | 0% | |
| 2. | 2,170,066 | $4,383,533 | 0% | |
| 3. | 2,048,757 | $4,138,489 | 0.91% | |
| 4. | 1,437,646 | $2,904,045 | 0.83% | |
| 5. | 901,555 | $1,821,142 | 0% |
News See All
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
Analysts on Wall Street Lower Ratings for These 10 Stocks
Amidst the anticipation surrounding pivotal economic indicators, European futures are on the ascent, signaling a cautious optimism among traders as they prepare for the release of crucial US inflation...
12 Most Shorted Stocks in 2024
Short-sellers may be annoying for corporations (and Redditors?), but investors usually find themselves thanking these companies for doing the often back-breaking and excruciating research that is required...
5 Most Shorted Stocks Right Now
Biomea Fusion, Inc. (NASDAQ:BMEA) is a biotechnology firm seeking to treat cancer and diabetes.
11 Best High Short Interest Stocks To Buy Now
In this piece, we will take a look at the 11 best high short interest stocks to buy now.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Jim Chanos, ValueAct Capital Management, Bridgewater Associates, GSD Capital, Pantera Capital, Biomea Fusion, Inc. (BMEA), and More
Activist fund ValueAct Capital Management LP said it’s looking forward to the opportunity to vote for new directors of Seven & i Holdings Co.